elestar 40 mg + 10 mg tabletki powlekane
menarini international operations luxembourg s.a. - olmesartanum medoxomilum + amlodipinum - tabletki powlekane - 40 mg + 10 mg
clatra allergy 20 mg tabletki
menarini international operations luxembourg s.a. - bilastyna - tabletki - 20 mg
ketesse sl 25 mg granulat do sporządzania roztworu doustnego
menarini international operations luxembourg s.a. - dexketoprofenum - granulat do sporządzania roztworu doustnego - 25 mg
zofenil plus 30 mg + 12,5 mg tabletki powlekane
menarini international operations luxembourg s.a. - zofenoprilum calcicum + hydrochlorothiazidum - tabletki powlekane - 30 mg + 12,5 mg
clatra 10 mg tabletki ulegające rozpadowi w jamie ustnej
menarini international operations luxembourg s.a. - bilastyna - tabletki ulegające rozpadowi w jamie ustnej - 10 mg
clatra 2,5 mg/ml roztwór doustny
menarini international operations luxembourg s.a. - bilastyna - roztwór doustny - 2,5 mg/ml
clatra 20 mg tabletki
menarini international operations luxembourg s.a. - bilastyna - tabletki - 20 mg
quofenix
a. menarini industrie farmaceutiche riunite s.r.l. - delafloxacin меглюмина - infekcje nabyte przez społeczność - Środki antybakteryjne do stosowania systemowego, - quofenix is indicated for the treatment of the following infections in adults:acute bacterial skin and skin structure infections (absssi),community-acquired pneumonia (cap), when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the initial treatment of these infections (see sections 4. 4 i 5. należy uwzględnić oficjalne zalecenia dotyczące właściwego stosowania antybiotyków agentów.
invokana
janssen-cilag international nv - canagliflozin - diabetes mellitus, type 2 - leki stosowane w cukrzycy - invokana is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise:as monotherapy when metformin is considered inappropriate due to intolerance or contraindicationsin addition to other medicinal products for the treatment of diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 i 5.
revival 40 mg tabletki powlekane
menarini international operations luxembourg s.a. - olmesartanum medoxomilum - tabletki powlekane - 40 mg